Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow margin | 2.1% | 4.5% | 5.9% | (0.0%) | (0.4%) | 2.8% | 5.8% | 2.8% | 4.4% | 4.7% | 5.0% | 5.8% | 3.3% | 8.3% | 10.7% | 13.1% | 13.9% | 11.7% | 15.2% | 14.1% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 11.2%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for West Pharmaceutical Services, Inc. have been 13.2% over the past three years, and 13.9% over the past five years.
As of today, West Pharmaceutical Services, Inc.'s Free Cash Flow margin is 11.2%, which is higher than industry median of 1.1%. It indicates that West Pharmaceutical Services, Inc.'s Free Cash Flow margin is Good.